Scrip
Plant-based Gaucher's drug passes Phase III trial
16 October 2009
Asher Mullard
Please Login to read the full article.
16 October 2009
Asher Mullard
Protalix Biotherapeutics' lead-drug candidate, Uplyso (taliglucerase alfa; formerly prGCD), was safe and effective in its pivotal Phase III trial, show top-line results. With these results, the company's Gaucher's disease therapy inches closer to becoming the first transgenicplant-produced...
Please Login to read the full article.
RELATED CONTENT
COMMENT
Other Informa Comment
FEATURES
Other Informa Features
EVENTS
17 March 2010
Berlin, Germany
17 March 2010
Berlin, Germany
22 March 2010
London, UK
JOB OF THE WEEK
Promote your vacancy here
DIRECTORY
Scrip Directory 2009
